Off-Label Guidance Creates ‘Safe Harbor’ For Dissemination of Certain Info To HCPs

The FDA's revised draft guidance on scientific communications to health care providers about unapproved uses of products describes the studies that are likely to be scientifically sound and clinically relevant. The agency also gives recommendations on presenting off-label information on web pages and in exhibit halls.